Broadening the Interpretation of the ‘Close Link’ Test to Take Account of Costs and Fees Incurred in Parallel EPO Proceedings

Clicks: 6
ID: 337429
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #37 of 38 articles by views in GRUR International

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Directive 2004/48/EC, Art. 14; Code of Civil Procedure, Art. 700 ‒ BioMérieux v Labrador Diagnostics 1. The costs and fees invoiced for the defence may be included in the amount to be reimbursed, notwithstanding that the pleadings on the merits, which were prepared, were not submitted to the court due to the summary proceedings seeking withdrawal and the interlocutory proceedings. 2. The costs and fees incurred in parallel EPO proceedings may be regarded as other expenses directly and closely related to the infringement proceedings and may therefore be reimbursable, at least in part. Appellant BioMérieux A public limited company registered at the commercial registry […] Respondent Labrador Diagnostics LLC A company incorporated under the laws of the United States and registered in the State of Nevada, represented by its current legal representatives, whose principal address is […]
Reference Key
openalex_W7224011524 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal GRUR International
Year 2026
DOI
10.1093/grurint/ikag101
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.